Home › Funds › WEITZ INVESTMENT MANAGEMENT, INC. › TECH

WEITZ INVESTMENT MANAGEMENT, INC. position in TECH

BIO-TECHNE CORP · Health Care

WEITZ INVESTMENT MANAGEMENT, INC. reported holding 252,300 shares of TECH (BIO-TECHNE CORP) in its Q3 2026 13F filing — a position valued at US$18.3M, representing 1.25% of its reported portfolio and ranking #24 among its reported holdings. WEITZ INVESTMENT MANAGEMENT, INC. has disclosed TECH holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)252.30K sh
Reported value held$18.28M
Portfolio Weight1.25%
First reportedQ2 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How WEITZ INVESTMENT MANAGEMENT, INC.'s TECH position evolved

WEITZ INVESTMENT MANAGEMENT, INC. first disclosed a stake in TECH in Q2 2024 at 44,100 shares (US$3.2M). The position peaked in Q4 2025 at 802,950 shares, worth US$47.2M. Across 10 filings, WEITZ INVESTMENT MANAGEMENT, INC. increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 252,300 shares valued at US$18.3M — a reduction of -290,900 shares quarter over quarter.. Notable position changes include a 708% increase in Q4 2024 (shares fell 19% over the following quarter), a 108% increase in Q1 2025 (shares fell 12% over the following quarter), a 54% trim in Q3 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 44.10K $3.16M New
Q3 2024 47.20K $3.77M Add
Q4 2024 381.25K $27.46M Add
Q1 2025 791.65K $46.41M Add
Q2 2025 802.15K $41.27M Add
Q3 2025 802.15K $44.62M Hold
Q4 2025 802.95K $47.22M Hold
Q1 2026 653.20K $34.14M Reduce
Q2 2026 543.20K $38.38M Reduce
Q3 2026 252.30K $18.28M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TECH and 13F data

TECH (BIO-TECHNE CORP) is a Health Care company. 27 other funds we track also report a position in TECH — the largest reported positions include HBK INVESTMENTS L P (US$482.2M), Ruane Cunniff & Goldfarb (Sequoia) (US$236.6M), SNYDER CAPITAL MANAGEMENT L P (US$223.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TECH

All TECH fund holders →

FAQ

How long has WEITZ INVESTMENT MANAGEMENT, INC. held TECH?

WEITZ INVESTMENT MANAGEMENT, INC. has disclosed TECH holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is WEITZ INVESTMENT MANAGEMENT, INC.'s current position in TECH?

As of Q3 2026, WEITZ INVESTMENT MANAGEMENT, INC. holds 252.30K shares of TECH (BIO-TECHNE CORP), valued at $18.28M, representing 1.25% of its reported portfolio and ranking #24.

Has WEITZ INVESTMENT MANAGEMENT, INC. been buying or selling TECH?

In the latest 13F filing (Q3 2026), WEITZ INVESTMENT MANAGEMENT, INC. reduced its position in TECH. The position peaked in Q4 2025 at 802.95K shares.

Which other funds hold TECH?

Other major institutional holders of TECH include HBK INVESTMENTS L P, Ruane Cunniff & Goldfarb (Sequoia), SNYDER CAPITAL MANAGEMENT L P, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.